Zhou Y - Search Results

1

Porphyromonas gingivalis as a promotor in the development of the alcoholic liver disease via ferroptosis.

Yao C, Lu L, Lan D, Zhu X, Li X, Gao Y, Zhou Y, Wang Y, Xu Y, Qi S. Yao C, et al. Among authors: zhou y. Microbes Infect. 2024 Mar-Apr;26(3):105250. doi: 10.1016/j.micinf.2023.105250. Epub 2023 Nov 13. Microbes Infect. 2024. PMID: 37967609

2

Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Zhang R, Cheng K, Xu S, Li S, Zhou Y, Zhou S, Kong R, Li L, Li J, Feng J, Wu L, Liu T, Xia Y, Lu J, Guo C, Zhou Y. Zhang R, et al. Among authors: zhou y, zhou s. Gastroenterol Res Pract. 2017;2017:8491742. doi: 10.1155/2017/8491742. Epub 2017 Jan 4. Gastroenterol Res Pract. 2017. PMID: 28133479 Free PMC article.

3

15-Deoxy-Δ^12,14-prostaglandin J₂ alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy.

Chen K, Li JJ, Li SN, Feng J, Liu T, Wang F, Dai WQ, Xia YJ, Lu J, Zhou YQ, Guo CY. Chen K, et al. Acta Pharmacol Sin. 2017 May;38(5):672-687. doi: 10.1038/aps.2016.108. Epub 2017 Feb 20. Acta Pharmacol Sin. 2017. PMID: 28216619 Free PMC article.

4

Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPARα Pathway.

Jiang Y, Yang W, Ding J, Ji J, Wu L, Zheng Y, Li Y, Cheng Z, Zhang J, Yu Q, Feng J, Li J, Wu J, Zhou Y, Guo C. Jiang Y, et al. Among authors: zhou y. PPAR Res. 2022 Aug 3;2022:8161946. doi: 10.1155/2022/8161946. eCollection 2022. PPAR Res. 2022. PMID: 35966821 Free PMC article.

5

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis.

Liu R, Zhu M, Chen J, Gai J, Huang J, Zhou Y, Wan Y, Tu C. Liu R, et al. Among authors: zhou y. Int J Nanomedicine. 2023 Sep 21;18:5407-5422. doi: 10.2147/IJN.S428430. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37753068 Free PMC article.

6

Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study.

Liu N, Feng J, Lv Y, Liu Q, Deng J, Xia Y, Guo C, Zhou Y. Liu N, et al. Among authors: zhou y. Exp Ther Med. 2019 Nov;18(5):4058-4066. doi: 10.3892/etm.2019.8011. Epub 2019 Sep 17. Exp Ther Med. 2019. PMID: 31611941 Free PMC article.

7

The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma.

Wang F, Dai W, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Li J, Zheng Y, Lu J, Yang J, Zhu R, Zhang H, Zhou Y, Xu L, Guo C. Wang F, et al. Among authors: zhou y. PLoS One. 2014 May 9;9(5):e97414. doi: 10.1371/journal.pone.0097414. eCollection 2014. PLoS One. 2014. PMID: 24816638 Free PMC article.

8

By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.

Dai W, Wang F, Lu J, Xia Y, He L, Chen K, Li J, Li S, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Abudumijiti H, Chen R, Zhang R, Zhou L, Zhou Z, Zhu R, Yang J, Wang C, Zhang H, Zhou Y, Xu L, Guo C. Dai W, et al. Among authors: zhou y, zhou z, zhou l. Oncotarget. 2015 May 30;6(15):13703-17. doi: 10.18632/oncotarget.3800. Oncotarget. 2015. PMID: 25938543 Free PMC article.

9

15-Deoxy- γ 12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPAR γ and Reduction in NF- κ B Activity.

Chen K, Li J, Wang J, Xia Y, Dai W, Wang F, Shen M, Cheng P, Zhang Y, Wang C, Yang J, Zhu R, Zhang H, Zheng Y, Lu J, Fan Z, Zhou Y, Guo C. Chen K, et al. Among authors: zhou y. PPAR Res. 2014;2014:215631. doi: 10.1155/2014/215631. Epub 2014 Jul 10. PPAR Res. 2014. PMID: 25120564 Free PMC article.

10

Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Liu N, Feng J, Lu X, Yao Z, Liu Q, Lv Y, Han Y, Deng J, Zhou Y. Liu N, et al. Among authors: zhou y. Mediators Inflamm. 2019 Jul 31;2019:6175091. doi: 10.1155/2019/6175091. eCollection 2019. Mediators Inflamm. 2019. PMID: 31467486 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,342 results

Search Page